Otc - Active Ingredient Section
For 600 mg:
Active ingredient (in each extended-release tablet)
Guaifenesin, USP 600 mg
For 1200 mg:
Active ingredient (in each extended-release tablet)
Guaifenesin, USP 1200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Marksans Pharma Limited for the product Guaifenesin 600 Mg (NDC 25000-042). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient section, otc - purpose section, indications & usage section, otc - do not use section, otc - ask doctor section, otc - stop use section, otc - pregnancy or breast feeding section, otc - keep out of reach of children section, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
For 600 mg:
Active ingredient (in each extended-release tablet)
Guaifenesin, USP 600 mg
For 1200 mg:
Active ingredient (in each extended-release tablet)
Guaifenesin, USP 1200 mg
Purpose
Expectorant
Uses
• helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Do not use
• for children under 12 years of age
Ask a doctor before use if you have
• persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
• cough accompanied by too much phlegm (mucus)
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Directions
For 600 mg
• do not crush, chew, or break extended - release tablet
• take with a full glass of water
• this product can be administered without regard for the timing of meals
• adults and children 12 years of age and over: 1 or 2 extended - release tablets every 12 hours. Do not exceed 4 extended - release tablets in 24 hours.
• children under 12 years of age: do not use
For 1200 mg
• do not crush, chew, or break extended - release tablet
• take with a full glass of water
• this product can be administered without regard for the timing of meals
• adults and children 12 years of age and over: 1 extended - release tablet every 12 hours. Do not exceed 2 extended - release tablets in 24 hours.
• children under 12 years of age: do not use
Other information
• store at 20-25°C (68-77°F)
Inactive ingredients colloidal silicon dioxide, copovidone, FD&C Blue No. 1 Aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone (K-30), sodium starch glycolate, stearic acid
Questions or comments?
Call 1-877-376-4271 (weekdays 9 AM to 5 PM)
You may also report side effects to this phone number.
Manufactured for:
Time-Cap Labs, Inc.
7 Michael Avenue,
Farmingdale,
NY 11735, USA
Manufactured by:
Marksans Pharma Ltd.
Plot No. L-82, L-83
Verna Indl. Estate
Verna, Goa-403722, India
NDC: 25000-042-55
Guaifenesin Extended-Release Tablets 600 mg
20's count (2 x 10's blister) Carton
NDC: 25000-042-01
Guaifenesin Extended-Release Tablets 600 mg
20's count Bottle Label
NDC: 25000-042-01
Guaifenesin Extended-Release Tablets 600 mg
20's count Bottle Carton
NDC: 25000-042-12
Guaifenesin Extended-Release Tablets 600 mg
500's count Bottle Label
NDC: 25000-041-75
Guaifenesin Extended-Release Tablets 1200 mg
12's count (2 x 6's blister) Carton
NDC: 25000-041-12
Guaifenesin Extended-Release Tablets 1200 mg
500's count Bottle Label
* Please review the disclaimer below.